Genscript Biotech Co. (OTCMKTS:GNNSF) Short Interest Up 16.7% in July

Genscript Biotech Co. (OTCMKTS:GNNSF) saw a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 6,519,800 shares, an increase of 16.7% from the July 15th total of 5,588,000 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 65,198.0 days.

Genscript Biotech Price Performance

Shares of Genscript Biotech stock remained flat at C$1.61 during trading hours on Friday. The firm’s 50-day simple moving average is C$1.33 and its two-hundred day simple moving average is C$1.58. Genscript Biotech has a 1 year low of C$1.05 and a 1 year high of C$3.20.

Genscript Biotech Company Profile

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.